Bovine Liver Hydrolysate

Bovine liver hydrolysate is a protein-derived supplement produced by enzymatic breakdown of bovine liver tissue, yielding bioactive peptides and free amino acids including ornithine, taurine, and heme-bound iron. Its primary mechanisms include stimulating ornithine decarboxylase activity to support hepatic regeneration and exerting antioxidant effects via radical scavenging peptides.

Origin & History

Bovine Liver Hydrolysate is a protein hydrolysate derived from cattle liver (Bos taurus), produced through enzymatic hydrolysis using proteases such as Alcalase/Protamex at controlled temperatures (45-55°C) and pH levels. The process yields bioactive peptides with molecular weights around 10 kDa through enzymatic digestion followed by centrifugation and sometimes ultrasonication.

Historical & Cultural Context

No historical or traditional medicine uses were documented in the available research. Current applications focus solely on modern food technology and research contexts rather than traditional healing practices.

Health Benefits

• Antioxidant activity: Demonstrates radical scavenging and reducing power, inhibiting lipid oxidation in emulsions and liposomes (in-vitro evidence only)
• Liver regeneration support: Stimulates liver regeneration in partially hepatectomized rats through increased ornithine decarboxylase activity (animal studies only)
• Cell proliferation: Increases proliferating cell nuclear antigen (PCNA) labeling index at 24 hours post-hepatectomy in rats (preliminary animal evidence)
• Protein supplementation: Provides low-molecular-weight peptides that may be more easily absorbed than intact proteins (theoretical benefit, no direct human evidence)
• Mineral content: Contains minerals from defatted bovine liver tissue (compositional data only, no clinical outcomes measured)

How It Works

Bovine liver hydrolysate stimulates hepatic regeneration by upregulating ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, which drives hepatocyte proliferation following liver injury. Bioactive peptides within the hydrolysate demonstrate free radical scavenging activity—likely via histidine-containing dipeptides and sulfur amino acids—inhibiting lipid peroxidation in membrane-like emulsion and liposome models. Additionally, heme-bound iron present in liver-derived fractions is absorbed via the HCP1 (heme carrier protein 1) pathway, bypassing the competitive inhibition affecting non-heme iron and improving bioavailability.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on bovine liver hydrolysate. The only human-related study focused on palatability of desiccated beef liver as complementary food rather than clinical outcomes. Evidence is limited to animal models showing liver regeneration effects in rats and in-vitro antioxidant assays.

Clinical Summary

The strongest mechanistic evidence for bovine liver hydrolysate comes from rodent models: partially hepatectomized rats administered hydrolysate fractions showed measurable increases in ornithine decarboxylase activity and accelerated liver mass restoration compared to controls. In-vitro studies confirm dose-dependent radical scavenging and lipid oxidation inhibition in emulsion and liposome systems, though these cannot be directly extrapolated to human physiology. Human clinical trials specifically on bovine liver hydrolysate as an isolated supplement are sparse; most human data derive from whole desiccated liver or liver extract products used historically for iron-deficiency anemia and fatigue. Overall, the evidence base is preliminary, consisting largely of animal and cell-based studies, and robust randomized controlled trials in humans are lacking.

Nutritional Profile

Bovine Liver Hydrolysate is a protein-rich ingredient derived from enzymatic or acid hydrolysis of bovine (cattle) liver tissue. Key nutritional components include: PROTEIN: High protein content, typically 60–85% dry weight basis, composed of short-chain peptides and free amino acids resulting from hydrolysis; rich in essential amino acids including lysine (~7–9% of protein), leucine (~8–10%), threonine (~4–5%), and branched-chain amino acids (BCAAs) collectively ~18–22%; notably high in glycine and proline from connective tissue fractions. HEME IRON: Naturally high heme iron content (~3–10 mg/100g depending on processing), with heme iron bioavailability estimated at 15–35%, significantly higher than non-heme iron sources; contributes to the ingredient's functional use in iron-deficiency applications. VITAMINS: Retains residual B-vitamins from liver source tissue, particularly vitamin B12 (cobalamin, potentially 10–60 µg/100g pre-processing; reduced post-hydrolysis), riboflavin (B2), niacin (B3), and folate, though concentrations are processing-dependent and typically reduced compared to whole liver. MINERALS: Contains zinc (~4–8 mg/100g), copper (~2–5 mg/100g), selenium (~15–40 µg/100g), and phosphorus; mineral retention is generally higher than vitamin retention post-hydrolysis. BIOACTIVE COMPOUNDS: Contains bioactive peptides liberated during hydrolysis with demonstrated antioxidant properties (radical scavenging peptides, typically 1–3 kDa molecular weight fractions); liver-specific growth factors and polyamine precursors (e.g., ornithine, a precursor to putrescine and spermidine) linked to observed ornithine decarboxylase activity; glutathione precursor amino acids (cysteine, glutamic acid, glycine) are present. FAT: Low residual lipid content, typically 1–5% dry weight after processing, with some retained phospholipids. BIOAVAILABILITY NOTES: Hydrolysis significantly improves peptide and amino acid absorption kinetics compared to intact protein; small peptides (di- and tri-peptides) are absorbed via PepT1 transporter, bypassing full proteolytic digestion; however, some heat-labile bioactive compounds and vitamins are partially degraded during hydrolysis processing. Exact concentrations vary substantially by hydrolysis method (enzymatic vs. acid), degree of hydrolysis (DH%), and source liver quality.

Preparation & Dosage

No clinically studied dosage ranges have been established in humans. Animal studies used oral administration with dose-dependent effects, but specific quantities were not reported. No standardization protocols for peptide content have been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, Alpha-lipoic acid, N-acetylcysteine, Vitamin E, Selenium

Safety & Interactions

Bovine liver hydrolysate is generally considered low-risk when sourced from tested, BSE-screened cattle, but individuals with gout or hyperuricemia should exercise caution due to high purine content that can elevate serum uric acid. The significant heme iron content may pose an iron overload risk in individuals with hemochromatosis or other iron dysregulation disorders, and concurrent use with iron supplements warrants monitoring. Bovine liver products may interact with warfarin due to high vitamin K content, potentially reducing anticoagulant efficacy. Pregnancy safety has not been formally established in clinical trials; while liver-derived nutrients like folate and iron are beneficial, the concentrated nature of the hydrolysate and the risk of excessive preformed vitamin A from liver sources warrants physician consultation before use during pregnancy.